Table 1 Baseline characteristics of the study population
| Â | Total | Male | Female |
|---|---|---|---|
|  | n = 18,779 | n = 4326 (23.0%) | n = 14,453 (77.0%) |
Age in years | |||
 Ø (SD) | 84.2 (7.1) | 82.5 (7.3) | 84.7 (6.9) |
 65–74 | 11.0% (n = 2073) | 16.1% (n = 697) | 9.5% (n = 1376) |
 75–84 | 34.7% (n = 6519) | 39,4% (n = 1704) | 33,3% (n = 4815) |
 85–94 | 50.6% (n = 9493) | 42.0% (n = 1816) | 53.1% (n = 7677) |
 95+ | 3.7% (n = 694) | 2.5% (n = 109) | 4.0% (n = 585) |
Care level | |||
 1 | 66.4% (n = 12,470) | 58.9% (n = 2549) | 68.6% (n = 9921) |
 2 | 29.4% (n = 5529) | 35.6% (n = 1539) | 27.6% (n = 3990) |
 3 | 4.2% (n = 780) | 5.5% (n = 238) | 3.8% (n = 542) |
Death within study period | |||
 Yes | 20.2% (n = 3784) | 26.9% (n = 1165) | 18.1% (n = 2619) |
 No | 79.8% (n = 14,995) | 73.1% (n = 3161) | 81.9% (n = 11,834) |
Disease prevalence | |||
 Diabetes | 31.7% (n = 5954) | 37.9% (n = 1639) | 29.9% (n = 4315) |
 Glaucoma | 14.0% (n = 2631) | 12.7% (n = 549) | 14.4% (n = 2082) |
 Depression | 31.2% (n = 5863) | 23.1% (n = 999) | 33.7% (n = 4864) |
 Dementia | 37.0% (n = 6951) | 39.5% (n = 1708) | 36.3% (n = 5243) |
 Parkinson’s disease | 7.7% (n = 1445) | 11.9% (n = 514) | 6.4% (n = 931) |
 Prostate hyperplasia | N/A | 38.6% (n = 1670) | N/A |